Hepatitis

Biden budget maintains domestic HIV funding & proposes PrEP & hepatitis C programs

“While we appreciate the proposed continued funding of  domestic HIV and hepatitis programs and acknowledge the legislatively imposed budget constraints and competing priorities, the reality is that, without serious increases, our nation cannot meet its goals to end the HIV and hepatitis epidemics on time,” commented Carl Schmid, Executive Director of the HIV+Hepatitis Policy Institute. “Now, we must take our case for any funding increases to Congress, which has found it difficult to agree on spending bills, and House Republicans have even proposed to cut domestic HIV spending this year by $767 million.”

read more

Senate appropriators maintain funding for domestic HIV programs

“While disappointed that Congress will not be providing the necessary funding to really end HIV or hepatitis in the United States, given the severe budget constraints, what the Senate has proposed will allow existing programs to at least continue,” Carl Schmid said. “However, it is up to the entire Congress, both the House and the Senate, to be responsible and agree upon our federal spending levels. The choices are very clear.”

read more

House proposes to gut ending HIV programs

“While we appreciate the sustained funding for many domestic HIV and hepatitis programs, we are devastated by the proposal to virtually eliminate the Ending the HIV Epidemic initiative,” said Carl Schmid, executive director of the HIV+Hepatitis Policy Institute. “We were on a trajectory to end HIV by ensuring all people have access to care and treatment, and prevent new infections through increasing access to PrEP, but now all those efforts will be lost. This bill cannot stand as is.”

read more

25 HIV and Hepatitis organizations file amicus brief to protect preventive services coverage

The HIV+Hepatitis Policy Institute and 24 other HIV and hepatitis organizations filed an amicus brief in support of the U.S. government in Braidwood Management v. Becerra, the challenge to the ACA’s preventive services coverage requirement, arguing, “A wholesale invalidation of the coverage requirement for USPSTF’s recommendations would strike a critical, unnecessary, and costly blow to the battle to end HIV, hepatitis, and other infectious diseases.”

read more

U.S. government must quickly act to stop Texas court decision on preventive services and PrEP

While not surprised by Judge O’Connor’s decision, which will immediately impact coverage of HIV testing, hepatitis B and C testing, along with PrEP, it is imperative that these critical preventive services must continue for the health of our nation. We expect that the U.S. government will quickly act to stay this decision so that preventive services can continue nationwide, and appeal it.

read more

Pin It on Pinterest